cillin allergy. Microbiology cultures identified Staphylococcus aureus that was sensitive to clindamycin. The drain was removed 3 days after insertion, and the antibiotics were administered for 2 weeks with clinical resolution of the abscess and no recurrence 8 months after treatment.
Phenylephrine hydrochloride is a direct-acting ␣ 1 -adrenergic agonist used for its mydriatic and vasoconstrictive properties. In addition to its ophthalmic uses, phenylephrine is used in the management of epistaxis for which it is instilled intranasally to induce vasoconstriction prior to cautery or packing. We describe a patient who developed sequential ipsilateral acute angleclosure attacks after intranasal phenylephrine use.
Report of a Case. At initial examination, a 67-year-old woman had right eye pain, redness, blurry vision, and nausea. Prior to the onset of symptoms, the patient had experienced right-sided epistaxis that was treated in an emergency department with intranasal 0.25% phenylephrine hydrochloride, topical tetracaine, silver nitrate cautery, and nasal packing. Visual acuity was 20/200 OD and 20/40 OS. The patient's refractive error was +1.75 diopters (D) OD and +2.00 D OS. The right pupil measured 7 mm and was nonreactive. The left pupil measured 4 mm and constricted to direct and consensual stimulation. Intraocular pressure was 62 mm Hg OD and 18 mm Hg OS. The right eye had conjunctival hyperemia, corneal edema, a quiet anterior chamber, and iris bombe. The lens had moderate nuclear sclerosis. Findings from the left eye were unremarkable, except for similar lens changes. There was a hazy view of the right fundus. The left fundus was normal, with a cupdisc ratio of 0.2.
The patient was treated with 1 drop of 0.5% timolol maleate and 2% dorzolamidehydrochloridetotheright eye followed by 100 mL of oral glycerin. This was repeated 15 minutes later. An attempt to create a Nd:YAG laser peripheral iridotomy was unsuccessful. The patient had multiple episodes of emesis during treatment, and she was transferred to the emergency department, where she received 12.5 g of intravenous mannitol and 1 drop of 4% pilocarpine hydrochloride. Intraocular pressure improved to 30 mm Hg. The patient was given 12.5 mgofpromethazinehydrochloridefor emesis and subsequently developed mentalstatuschanges,andshewasadmitted for observation.
The evening prior to hospital discharge, the patient had an episode of left-sided epistaxis and was emergently treated, without ophthalmic consultation, with intranasal 0.25% phenylephrine hydrochloride and nasal packing by the hospital staff (not affiliated with the hospital of initial examination) who were unaware of the inciting event of her angle-closure attack. The following day the patient was seen for left eye pain, redness, and blurry vision. Visual acuity was 20/100 OS, and there was corneal edema and iris bombe. Intraocular pressure was 42 mm Hg. The patient was treated with 2% pilocarpine hydrochloride and 0.2% brimonidine tartrate to the left eye and underwent Nd:YAG laser peripheral iridotomy in the left eye as well as revision of iridotomy in the right eye. Intraocular pressure normalized in both eyes.
The patient was referred to the Kresge Eye Institute/Detroit Medical Center. Visual acuity was 20/40 OD and20/30OS.Intraocularpressurewas 17 mm Hg OD and 16 mm Hg OS. Therewere2patentperipheraliridoto-mies in the right iris and 1 patent iridotomy in the left iris. Fundus examination findings were normal in both eyes.
Comment. To our knowledge, there are no previously reported cases of acute angle-closure glaucoma secondary to the intranasal application of phenylephrine. Phenylephrine is frequently used in the acute management of epistaxis because of its vasoconstrictive properties. Our patient experienced sequential angleclosure attacks after the administration of intranasal phenylephrine that likely were precipitated by phenylephrine-induced pupillary mydriasis in the ipsilateral eye. Previous reports of angle-closure glaucoma induced by intranasally administered substances have been reported.
1,2 Hari et al 1 reported a case of acute angle-closure glaucoma after ipsilateral intraoperative painting of the nasal mucosa with 25% cocaine paste. Mitchell and Schwartz 2 described a patient with a history of cocaine abuse who developed angleclosure glaucoma ipsilateral to the intranasal use (the patient had a traumatically deviated septum and could only use 1 naris). In these cases, like ours, the angle closure occurred in the ipsilateral eye. There is some evidence that intranasally administered aerosolized medications may reflux through the ipsilateral nasolacrimal duct and be detected in tears. 3 Systemic absorption through the nasal mucosa is another possible mechanism of action. Physicians should be aware of this uncommon cause of acute angleclosure glaucoma.
